14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0135 $0.0135 Friday, 5th Apr 2024 ATHX stock ended at $0.0135. During the day the stock fluctuated 0% from a day low at $0.0135 to a day high of $0.0135.
90 days $0.0116 $0.0212
52 weeks $0.0116 $1.14

Historical Athersys prices

Date Open High Low Close Volume
Jan 24, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 23, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 22, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 19, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 18, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 17, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 16, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 12, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 11, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 10, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 09, 2024 $0.0135 $0.0135 $0.0135 $0.0135 0
Jan 08, 2024 $0.0177 $0.0212 $0.0116 $0.0135 6 462 682
Jan 05, 2024 $0.0210 $0.0235 $0.0190 $0.0203 1 028 951
Jan 04, 2024 $0.0220 $0.0240 $0.0205 $0.0215 294 002
Jan 03, 2024 $0.0200 $0.0239 $0.0200 $0.0239 910 269
Jan 02, 2024 $0.0190 $0.0230 $0.0190 $0.0202 131 754
Dec 29, 2023 $0.0190 $0.0230 $0.0170 $0.0200 1 586 538
Dec 28, 2023 $0.0238 $0.0238 $0.0190 $0.0211 567 679
Dec 27, 2023 $0.0210 $0.0240 $0.0189 $0.0238 1 008 528
Dec 26, 2023 $0.0260 $0.0260 $0.0200 $0.0230 623 009
Dec 22, 2023 $0.0190 $0.0260 $0.0190 $0.0260 458 784
Dec 21, 2023 $0.0230 $0.0259 $0.0152 $0.0246 976 369
Dec 20, 2023 $0.0260 $0.0260 $0.0220 $0.0259 400 856
Dec 19, 2023 $0.0213 $0.0260 $0.0202 $0.0250 443 017
Dec 18, 2023 $0.0249 $0.0260 $0.0230 $0.0231 229 447
Click to get the best stock tips daily for free!

About Athersys

Athersys Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study f... ATHX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT